CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,234 Cr | ₹-1,293 Cr | ₹-1,200 Cr | ₹-958 Cr | ₹-1,600 Cr |
What is the latest Cash Flow from Financing Activities ratio of CIPLA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1,234 Cr |
| Mar2025 | ₹-1,293 Cr |
| Mar2024 | ₹-1,200 Cr |
| Mar2023 | ₹-958 Cr |
| Mar2022 | ₹-1,600 Cr |
How is Cash Flow from Financing Activities of CIPLA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,234 Cr | Negative | |
| Mar2025 | ₹-1,293 Cr | Negative | |
| Mar2024 | ₹-1,200 Cr | Negative | |
| Mar2023 | ₹-958 Cr | Negative | |
| Mar2022 | ₹-1,600 Cr | - | |
Compare Cash Flow from Financing Activities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹109,113.6 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
| MANKIND PHARMA | ₹97,611.6 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.3% |
-5.3% |
-9.8% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses